Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Edwards v Meril: 3 insights from the UPC Court of Appeal’s decision
Europe
With its landmark ruling, the court has delivered guidance for patentees and litigants— including three takeaways for counsel and rights holders, explain Tobias Wuttke and Axel Berger of Bardehle Pagenberg.   19 December 2025
Abbott wins appeal to restore glucose monitoring patent
Europe
A UK appellate court has revived a key patent for the tech, finding flaws in the lower court’s handling of the case and obviousness analysis over prior art.   18 December 2025
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
Americas
The proponents of a petition denied by the Supreme Court said it addressed a conflict that was significant “not just for the pharmaceutical industry, but for all stakeholders in our patent system”.   17 December 2025
Careers
The firm’s new hire is known for advising Boston’s biotech, pharmaceutical and chemical companies on patent strategies and commercialising scientific inventions.   17 December 2025
Europe
UK court hears claims that a delay and construction inconsistency led to the alleged wrongful invalidation of a patent at the heart of a global dispute.   16 December 2025
Careers
The proposed 1,400-strong firm will combine Taylor Wessing's top UK and European practice with Winston & Strawn's US-focused IP litigation team.   15 December 2025
Europe
The country aims to become the world’s third-largest life sciences economy by 2035, but stalled investments, regulatory hurdles, and talent shortages are raising questions about whether the target is achievable, finds Marisa Woutersen.   15 December 2025
Americas
Israeli drug maker bows to FTC pressure, removing scores of “improperly listed” patents in boon for generic manufacturers.   11 December 2025
Careers
The lateral hire from Covington & Burling will strengthen the firm's cross-border expertise as the UK and EU markets ‘navigate regulatory and technological shifts’, said the firm.   11 December 2025
Asia
The Danish pharma giant is expanding its patent defence in India as multiple generics prepare to challenge its blockbuster diabetes and weight-loss drug ahead of 2026 patent expiry.   9 December 2025